Cornerstone Wealth Management’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$394K Sell
10,255
-375
-4% -$14.4K 0.02% 441
2025
Q1
$412K Buy
10,630
+1,091
+11% +$42.3K 0.03% 412
2024
Q4
$323K Sell
9,539
-964
-9% -$32.6K 0.02% 446
2024
Q3
$429K Sell
10,503
-877
-8% -$35.9K 0.03% 387
2024
Q2
$438K Buy
11,380
+97
+0.9% +$3.74K 0.03% 352
2024
Q1
$484K Sell
11,283
-3,067
-21% -$131K 0.04% 332
2023
Q4
$532K Sell
14,350
-656
-4% -$24.3K 0.05% 312
2023
Q3
$544K Buy
15,006
+59
+0.4% +$2.14K 0.05% 283
2023
Q2
$533K Sell
14,947
-7
-0% -$249 0.05% 294
2023
Q1
$532K Buy
+14,954
New +$532K 0.05% 276
2022
Q3
$424K Buy
14,402
+300
+2% +$8.83K 0.05% 291
2022
Q2
$767K Buy
14,102
+8,592
+156% +$467K 0.09% 194
2022
Q1
$300K Sell
5,510
-433
-7% -$23.6K 0.03% 366
2021
Q4
$327K Buy
5,943
+1,386
+30% +$76.3K 0.03% 366
2021
Q3
$218K Buy
4,557
+100
+2% +$4.78K 0.02% 417
2021
Q2
$222K Sell
4,457
-2,479
-36% -$123K 0.02% 428
2021
Q1
$309K Sell
6,936
-182
-3% -$8.11K 0.04% 346
2020
Q4
$327K Sell
7,118
-478
-6% -$22K 0.04% 318
2020
Q3
$357K Buy
7,596
+3,149
+71% +$148K 0.05% 269
2020
Q2
$227K Buy
4,447
+169
+4% +$8.63K 0.04% 336
2020
Q1
$203K Sell
4,278
-274
-6% -$13K 0.04% 326
2019
Q4
$267K Sell
4,552
-619
-12% -$36.3K 0.04% 286
2019
Q3
$276K Sell
5,171
-926
-15% -$49.4K 0.05% 277
2019
Q2
$304K Buy
6,097
+332
+6% +$16.6K 0.05% 279
2019
Q1
$324K Sell
5,765
-537
-9% -$30.2K 0.04% 366
2018
Q4
$299K Sell
6,302
-398,312
-98% -$18.9M 0.06% 260
2018
Q3
$12.5M Buy
404,614
+120,880
+43% +$3.72M 0.16% 144
2018
Q2
$8.84M Buy
283,734
+276,849
+4,021% +$8.63M 0.1% 215
2018
Q1
$333K Sell
6,885
-1,980
-22% -$95.8K 0.06% 279
2017
Q4
$416K Sell
8,865
-1,101
-11% -$51.7K 0.08% 253
2017
Q3
$504K Buy
9,966
+4,413
+79% +$223K 0.1% 199
2017
Q2
$292K Buy
5,553
+429
+8% +$22.6K 0.07% 290
2017
Q1
$267K Buy
+5,124
New +$267K 0.07% 268